[Canadian Consensus Conference on Coronary Thrombolysis--current aspects].
作者信息
Cairns J, Armstrong P, Belenkie I, Hirsh J, Johnstone D, Knudtson M, Lemieux M, Massel D, Naylor D, Roy L
机构信息
Department of Medicine, McMaster University Medical Centre, Hamilton, Ontario.
出版信息
Can J Cardiol. 1995 Jul-Aug;11(7):581-6.
PMID:7656193
Abstract
摘要
相似文献
1
[Canadian Consensus Conference on Coronary Thrombolysis--current aspects].[加拿大冠状动脉溶栓共识会议——当前情况]
Can J Cardiol. 1995 Jul-Aug;11(7):581-6.
2
3
Tissue-type plasminogen activator for acute coronary thrombosis.用于急性冠状动脉血栓形成的组织型纤溶酶原激活剂。
Med Lett Drugs Ther. 1987 Dec 4;29(754):107-9.
4
Perspectives on therapeutic interventions in patients with acute myocardial infarction: viewpoints after the GISSI-2 results.
Clin Cardiol. 1991 Jul;14(7):549-56.
5
What you should know about thrombolytic therapy for acute MI.关于急性心肌梗死溶栓治疗你应该了解的内容。
Am J Nurs. 1993 Sep;93(9):24-31; quiz 33.
6
Thrombolytic therapy of myocardial infarction--it's time for science, not marketing: the perspective of a practicing cardiologist.
Clin Cardiol. 1991 Jul;14(7):548.
7
[My practice of thrombolysis in the acute phase of myocardial infarction in the light of extensive studies].[基于广泛研究的心肌梗死急性期溶栓治疗实践]
Ann Cardiol Angeiol (Paris). 1992 Dec;41(10):595-7.
8
9
Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I.美国和加拿大急性心肌梗死患者的长期死亡率：对参与“冠状动脉闭塞时链激酶和组织型纤溶酶原激活剂的全球应用研究（GUSTO-I）”的患者的比较。
Circulation. 2004 Sep 28;110(13):1754-60. doi: 10.1161/01.CIR.0000142671.06167.91. Epub 2004 Sep 20.
10
Canadian Consensus Conference on Coronary Thrombolysis--1994 update.加拿大冠状动脉溶栓共识会议——1994年更新版
Can J Cardiol. 1994 Jun;10(5):517-21.
引用本文的文献
1
Enhancing Thrombolysis with Adjunctive Therapy.辅助治疗增强溶栓作用
J Thromb Thrombolysis. 1996;3(2):135-143. doi: 10.1007/BF00132406.
Zotero 插件